Prudential Financial’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.2M | Buy |
185,820
+21,250
| +13% | +$1.53M | 0.02% | 534 |
|
|
2026
Q1 | $11.2M | Sell |
164,570
-18,615
| -10% | -$1.32M | 0.01% | 589 |
|
|
2025
Q4 | $13.9M | Buy |
183,185
+95,745
| +109% | +$6.96M | 0.02% | 514 |
|
|
2025
Q3 | $5.37M | Buy |
87,440
+3,190
| +4% | +$166K | 0.01% | 895 |
|
|
2025
Q2 | $4.11M | Buy |
84,250
+22,060
| +35% | +$1.05M | 0.01% | 1024 |
|
|
2025
Q1 | $3.17M | Buy |
62,190
+56,570
| +1,007% | +$2.82M | ﹤0.01% | 1067 |
|
|
2024
Q4 | $254K | Sell |
5,620
-330
| -6% | -$14.1K | ﹤0.01% | 2033 |
|
|
2024
Q3 | $221K | Buy |
+5,950
| New | +$199K | ﹤0.01% | 2490 |
|
|
2023
Q3 | – | Sell |
-5,833
| Closed | -$244K | – | 2680 |
|
|
2023
Q2 | $244K | Buy |
5,833
+152
| +3% | +$7.44K | ﹤0.01% | 2368 |
|
|
2023
Q1 | $238K | Sell |
5,681
-148,100
| -96% | -$6.77M | ﹤0.01% | 2343 |
|
|
2022
Q4 | $5.87M | Sell |
153,781
-10,866
| -7% | -$452K | 0.01% | 802 |
|
|
2022
Q3 | $8.27M | Sell |
164,647
-22,483
| -12% | -$1.1M | 0.01% | 709 |
|
|
2022
Q2 | $7.5M | Sell |
187,130
-12,612
| -6% | -$442K | 0.01% | 760 |
|
|
2022
Q1 | $7.45M | Buy |
199,742
+63,729
| +47% | +$2.46M | 0.01% | 807 |
|
|
2021
Q4 | $5.66M | Buy |
136,013
+11,659
| +9% | +$446K | 0.01% | 958 |
|
|
2021
Q3 | $4.63M | Buy |
124,354
+41,248
| +50% | +$1.69M | 0.01% | 1024 |
|
|
2021
Q2 | $3.51M | Sell |
83,106
-144,623
| -64% | -$6.2M | ﹤0.01% | 1183 |
|
|
2021
Q1 | $10.8M | Buy |
227,729
+22,846
| +11% | +$1.36M | 0.02% | 732 |
|
|
2020
Q4 | $12.5M | Sell |
204,883
-20,470
| -9% | -$1.21M | 0.02% | 654 |
|
|
2020
Q3 | $10.5M | Buy |
225,353
+30,960
| +16% | +$1.52M | 0.02% | 633 |
|
|
2020
Q2 | $9.86M | Buy |
194,393
+94,615
| +95% | +$4.65M | 0.02% | 695 |
|
|
2020
Q1 | $4.45M | Sell |
99,778
-90,989
| -48% | -$4.58M | 0.01% | 969 |
|
|
2019
Q4 | $9.16M | Sell |
190,767
-136,052
| -42% | -$5.78M | 0.01% | 890 |
|
|
2019
Q3 | $11.1M | Buy |
326,819
+35,139
| +12% | +$1.53M | 0.02% | 773 |
|
|
2019
Q2 | $13.1M | Buy |
291,680
+54,069
| +23% | +$2.14M | 0.02% | 719 |
|
|
2019
Q1 | $8.94M | Buy |
+237,611
| New | +$7.98M | 0.01% | 886 |
|
|
2018
Q4 | – | Sell |
-24,280
| Closed | -$1.14M | – | 2434 |
|
|
2018
Q3 | $1.14M | Sell |
24,280
-59,610
| -71% | -$2.47M | ﹤0.01% | 1831 |
|
|
2018
Q2 | $2.83M | Buy |
+83,890
| New | +$2.62M | ﹤0.01% | 1477 |
|
|
2017
Q4 | – | Sell |
-51,227
| Closed | -$1.02M | – | 2355 |
|
|
2017
Q3 | $1.02M | Buy |
51,227
+40,212
| +365% | +$787K | ﹤0.01% | 1829 |
|
|
2017
Q2 | $201K | Buy |
+11,015
| New | +$148K | ﹤0.01% | 2256 |
|
|
2016
Q2 | – | Sell |
-108,850
| Closed | -$701K | – | 2322 |
|
|
2016
Q1 | $701K | Buy |
108,850
+19,300
| +22% | +$335K | ﹤0.01% | 1928 |
|
|
2015
Q4 | $2.9M | Buy |
+89,550
| New | +$2.64M | 0.01% | 1331 |
|
Other funds holding PTCT
RI
JT
Prudential Financial's PTCT Position: Q2 2026 in Review
Prudential Financial increased its PTC Therapeutics (PTCT) stake by 13% in Q2 2026, buying an estimated $1.53M and bringing the position to 185,820 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #534.
Prudential Financial first reported a position in PTCT in Q4 2015 and has held it in 32 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Prudential Financial held 185,820 shares of PTC Therapeutics worth $15.2M as of Q2 2026.
- Prudential Financial bought 21,250 PTC Therapeutics shares in Q2 2026, an estimated $1.53M.
- PTC Therapeutics made up 0.02% of Prudential Financial's portfolio in Q2 2026, its #534 holding.
- Prudential Financial first reported a position in PTC Therapeutics in Q4 2015 and has held it in 32 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.